Institute of Human Genetics Polish Academy of Sciences, 60-479 Poznań, Poland.
Department of Systems Biology and Engineering, Silesian University of Technology, 44-100 Gliwice, Poland.
Cells. 2020 May 5;9(5):1137. doi: 10.3390/cells9051137.
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy arising from T lymphocyte precursors. We have previously shown by miRNA-seq, that miRNAs from the mir-106a-363 cluster are overexpressed in pediatric T-ALL. In silico analysis indicated their potential involvement in the regulation of apoptosis. Here, we aimed to test the hypothesis on the pro-tumorigenic roles of these miRNAs in T-ALL cells in vitro. We demonstrate, for the first time, that hsa-miR-20b-5p and hsa-miR-363-3p from the mir-106a-363 cluster, when upregulated in T-ALL cells in vitro, protect leukemic cells from apoptosis, enhance proliferation, and contribute to growth advantage. We show, using dual luciferase reporter assays, Ago2-RNA immunoprecipitation, RT-qPCR, and Western blots, that the oncogenic effects of these upregulated miRNAs might, at least in part, be mediated by the downregulation of two important tumor suppressor genes, and , targeted by both miRNAs. Additionally, we demonstrate the cooperative effects of these two miRNAs by simultaneous inhibition of both miRNAs as compared to the inhibition of single miRNAs. We postulate that hsa-miR-20b-5p and hsa-miR-363-3p from the mir-106a-363 cluster might serve as oncomiRs in T-ALL, by contributing to post-transcriptional repression of key tumor suppressors, and .
T 细胞急性淋巴细胞白血病 (T-ALL) 是一种起源于 T 淋巴细胞前体的侵袭性恶性肿瘤。我们之前通过 miRNA-seq 发现,miR-106a-363 簇中的 miRNA 在儿科 T-ALL 中过度表达。计算机分析表明它们可能参与调节细胞凋亡。在这里,我们旨在检验这些 miRNA 在体外 T-ALL 细胞中具有促肿瘤作用的假设。我们首次证明,miR-106a-363 簇中的 hsa-miR-20b-5p 和 hsa-miR-363-3p 在体外上调时,可保护白血病细胞免于凋亡、增强增殖,并有助于生长优势。我们通过双荧光素酶报告基因检测、Ago2-RNA 免疫沉淀、RT-qPCR 和 Western blot 实验表明,这些上调 miRNA 的致癌作用至少部分可能是通过下调两个重要的肿瘤抑制基因 和 来介导的,这两个基因均是这两种 miRNA 的靶基因。此外,我们通过同时抑制两种 miRNA 来证明这两种 miRNA 的协同作用,与单独抑制单种 miRNA 相比。我们假设,miR-106a-363 簇中的 hsa-miR-20b-5p 和 hsa-miR-363-3p 可能作为 T-ALL 中的癌基因,通过对关键肿瘤抑制基因 和 的转录后抑制做出贡献。